Last reviewed · How we verify
NCT05203770
Adaptations of the Brain in Chronic Pain With Opioid Exposure I
trial in Chronic Back Pain in 250 participants. Status unknown.
23 February 2023
Quick facts
| Lead sponsor | Northwestern University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 31 October 2018 |
| Primary completion | 23 February 2023 |
| Estimated completion | 30 June 2024 |
| Sites | 2 locations across United States |
Conditions studied
- Chronic Back Pain — all drugs for Chronic Back Pain →
- Opioid Use — all drugs for Opioid Use →
Sponsor
Northwestern University
Who can join
18 and older, any sex, with Chronic Back Pain or Opioid Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates brain reorganization and behavioral responses in chronic pain with opioid exposure in Chronic Back Pain (CBP).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05203770
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Back Pain
Currently open trials in the same condition.
- NCT07529392 — Percutaneous Auricular Vagus Nerve Stimulation With Conventional Rehabilitation Training in Chronic Back Pain Patients · Phase 4 · recruiting
- NCT07244237 — Assessing Spinal Pain With an Artificial Intelligence-assisted Whole Body Electrical Stimulation Device · recruiting
- NCT07198412 — Effect of Sedation After Ultrasound-Guided Spinal Anesthesia on Back Pain · NA · recruiting
- NCT07033195 — Virtual Reality Treatment for Adults With Chronic Back Pain (VRNT) · NA · recruiting
- NCT06641102 — Healing Track Clinical Trial · NA · recruiting
Other Northwestern University trials
Trials by the same sponsor.
- NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
- NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
- NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
- NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
- NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05203770 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwestern University
- Last refreshed: 19 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05203770.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing